Bayer

Showing 15 posts of 262 posts found.

Bayer image

Bayer justifies Brandicourt’s ‘golden handshake’

February 27, 2015
Medical Communications, Sales and Marketing Bayer, CEO, Sanofi, dekkers, olivier brandicourt, payments, wages

Bayer has confirmed that Sanofi’s justification for the controversial starter package it is giving to the German firm’s Olivier Brandicourt …

richard_pott_bayer

Bayer MaterialScience gets new chairman

February 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Werner Baumann, richard pott

Dr Richard Pott has been appointed to the supervisory board at Bayer MaterialScience as its new chairman. Pott replaces Werner …

Bayer image

New drugs give Bayer record sales

February 26, 2015
Sales and Marketing Bayer, Eylea, Radium-223 chloride, Stivarga, Xarelto, adempas, aflibercept, dekkers, german, regorafenib, riociguat, xofigo

Bayer has reported strong financial results for 2014 driven primary by sales of new medicines, although controversy surrounding its anti-clotting …

Olivier Brandicourt image

Sanofi confirms new chief executive

February 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Chris Viehbacher, Sanofi, praluent

Bayer chairman Olivier Brandicourt has been named as Sanofi’s new chief executive to replace Chris Viehbacher who was ejected from …

UK pharma commits at least ‘one code breach a week’

February 18, 2015
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code

Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

oliver_zuhlke

New chairman for Bayer’s Central Works Council

February 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Zühlke, Thomas de Win, central works council

Oliver Zühlke has succeeded Thomas de Win as chairman at the Central Works Council of Bayer as he steps down …

Bayer image

Bayer launches major new stroke trial

January 27, 2015
Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke

Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …

Xarelto image

NICE recommends Bayer heart attack drug

January 26, 2015
Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …

Boehringer image

Boehringer trials Pradaxa anti-bleeding antidote

December 11, 2014
Sales and Marketing BMS, Bayer, Boehringer, Eliquis, Pradaxa, ash, dabigatran, idarucizumab

Boehringer Ingelheim says that its investigational drug can safely reverse the blood-thinning effect of its anti-clotting drug Pradaxa (dabigatran). The …

bayer_healthcare

Mixed results for new leukaemia drugs

December 9, 2014
Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …

Bayer image

Bayer files haemophilia drug in EU

December 5, 2014
Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate

Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …

klaus_schafer_bayer

New head of industrial operations at Bayer

November 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Klaus Schäfer

Bayer MaterialScience is getting a new head of industrial operations and technology as Dr Tony Van Osselaer retires from the …

Supervisory board member joins Bayer

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler

Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …

malini_moorthy

Bayer hires litigation head from Pfizer

July 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer

Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US.  Moorthy joins the German firm from …

Bayer in Oxford tie-up

July 11, 2014
Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university

Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …

The Gateway to Local Adoption Series

Latest content